Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actemra in steroid refractory acute GVHD
NCT01475162Phase 2Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Aug 2011
- Primary completion
- Feb 2016
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of tocilizumab in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Medical College of Wisconsin. Started Aug 2011; status: terminated.
02
Drugs
tocilizumab
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT01475162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475162.